 |
|
Home | JPMorgan Chase Now Covering Dynavax Technologies (DVAX) |
 |
JPMorgan Chase Now Covering Dynavax Technologies (DVAX)
|
 |
- January 02, 2013
-
Equities researchers at JPMorgan Chase began coverage on shares of Dynavax Technologies (NASDAQ: DVAX) in a report issued on Wednesday. The firm set a “neutral” rating on the stock. The analysts wrote, “We are initiating coverage of Dynavax (DVAX) with a Neutral rating. Dynavax is a clinical stage biotechnology company with a focus on infectious [...]This article (JPMorgan Chase Now Covering Dynavax Technologies (DVAX)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2013/01/02/jpmorgan-chase-now-covering-dynavax-technologies-dvax/
|
 |
|
 |
|
 |
